Lieberknecht, S. and Vehreschild, M. J. G. T. (2020). Update on Clostridioidesdifficile infection. Gastroenterologe, 15 (3). S. 168 - 178. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1861-969X
Full text not available from this repository.Abstract
Background New findings warrant the re-evaluation of diagnostic and therapeutic recommendations on the management of Clostridioides difficile infection (CDI). Objectives To provide a clinical evaluation of novel findings on the diagnosis and treatment of CDI. Materials and methods Review of the literature and provision of an expert opinion. Results To establish the diagnosis of CDI, a two-stage strategy with a highly sensitive glutamate dehydrogenase enzyme immunoassay (GDH-EIA) or nucleic acid amplification test (NAAT) followed by a specific toxin A/B EIA is recommended. With the exception of individual, well-argued cases, oral metronidazole should no longer be used for the treatment of CDI. Fidaxomicin is superior to vancomycin with respect to prevention of recurrence. Bezlotoxumab has been introduced as a new option for secondary prophylaxis, in particular for patients with recurrent CDI. Fecal microbiota transfer (FMT) is another secondary prophylaxis option with high clinical efficacy. At this point, it is, however, only available in the context of an individualized treatment trial. Conclusions Based on an improved understanding of the pathophysiology of CDI and on published clinical data, we recommend fidaxomicin as the treatment of choice for the first episode, as well as for the treatment of recurrence, independent of the severity of disease. In clinical practice, the implementation of this evidence-based recommendation is often hampered by the high market price of fidaxomicin. In this context, we recommend prioritization of patients with a high risk of recurrence or who would benefit from a diverse microbiota during their further course of treatment, e.g. those undergoing or being scheduled for allogeneic stem cell transplantation.
Item Type: | Journal Article | ||||||||||||
Creators: |
|
||||||||||||
URN: | urn:nbn:de:hbz:38-340516 | ||||||||||||
DOI: | 10.1007/s11377-020-00435-w | ||||||||||||
Journal or Publication Title: | Gastroenterologe | ||||||||||||
Volume: | 15 | ||||||||||||
Number: | 3 | ||||||||||||
Page Range: | S. 168 - 178 | ||||||||||||
Date: | 2020 | ||||||||||||
Publisher: | SPRINGER HEIDELBERG | ||||||||||||
Place of Publication: | HEIDELBERG | ||||||||||||
ISSN: | 1861-969X | ||||||||||||
Language: | German | ||||||||||||
Faculty: | Unspecified | ||||||||||||
Divisions: | Unspecified | ||||||||||||
Subjects: | no entry | ||||||||||||
Uncontrolled Keywords: |
|
||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/34051 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |